Our Investors

NovioSense BV is a venture backed medical device company. We have successfully closed four seed rounds of investment in 2012, 2014, 2015 and 2016 respectively.  NovioSense is currently actively seeking both strategic partners and risk capital to accelerate the development of our technology to the clinical validation and market entry. We expect to begin market introduction Q1 2020.

Existing investors

logo-2Health Innovations invests in technology driven start ups in healthcare. Shareholders in our funds are ABN AMRO Bank, two healthcare insurers: Achmea and VGZ and Mediq, an international distributor in healthcare.

logoParticipatiemaatschappij Oost Nederland NV (PPM Oost) invests public money in promising companies that are contributing to a flourishing economy in the East Netherlands, especially in the food, health and technology sectors. PPM Oost has invested in more than 150 companies. PPM Oost also manages and executes the Provincial Innovation and Investment Fund Gelderland (IIG), a recently established revolving fund that is focusing on the strategic areas Food, Health, Energy and Environmental Technology.

logo imsThe Fraunhofer-Gesellschaft promotes and conducts applied research in an international context to benefit private and public enterprise and is an asset to society as a whole.

NovioTech16-1NovioTech BV is based in Nijmegen, the Netherlands and focuses on high tech solutions in the domains of Life Sciences and new  materials. NovioTech works closely together with academia and research centers and has a wide international network both in clinical research, industry and finance.